Research Paper Advance Articles pp 23761—23777

Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma

Figure 1. Bioinformatics prediction. (A) GEO: (GSE76297), Normal: n=92, CCA: n=91, (p<0.001). (B) TCGA database, Normal: n=9, CCA: n=36, (p<0.001). Protein="" and="" mRNA="" expression="" of="" KIAA1199="" in="" CCA="" tissues="" cell="" lines:="" (C) The relative expression levels of KIAA1199 in Pathological sections. (D) The relative protein expression levels of KIAA1199 in 20 pairs of CCA and adjacent normal tissues(p<0.001). (E) The relative mRNA expression levels of KIAA1199 in 20 pairs of CCA and adjacent normal tissues(p<0.001). (F, G) The relative protein and mRNA expression of KIAA1199 in four CCA cell lines.